Xianheng International Science&Technology (605056) Fundamentals 2026 — P/E 18.8x, Revenue Analysis | SniperIQ
Xianheng International Science&Technology (605056) is a CN-listed Industrials company in Manufacturing - Tools & Accessories with a market capitalization of ¥5.2B, trading at ¥12.66 on the SHH. This SniperIQ fundamentals page covers Xianheng International Science&Technology's valuation (P/E 18.8x, P/B 2.8x), profitability (net margin 5.5%), revenue (¥4.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Xianheng International Science&Technology's market cap?
Xianheng International Science&Technology (605056) has a market capitalization of approximately ¥5.2B, trading at ¥12.66 on the SHH. Market cap moves with the live share price.
What is Xianheng International Science&Technology's P/E ratio?
Xianheng International Science&Technology's trailing twelve-month P/E ratio is 18.8x, with a price-to-book (P/B) of 2.8x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Xianheng International Science&Technology?
Xianheng International Science&Technology runs a net profit margin of 5.5%, a gross margin of 23.0%, and an operating margin of 7.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Xianheng International Science&Technology generate?
Xianheng International Science&Technology reported revenue of ¥4.5B for fiscal year 2025, with net income of ¥260M and earnings per share (EPS) of 0.65. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Xianheng International Science&Technology pay a dividend?
Xianheng International Science&Technology offers a trailing dividend yield of about 3.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Xianheng International Science&Technology financially healthy?
Xianheng International Science&Technology carries a debt-to-equity ratio of 0.10x and a current ratio of 1.53x, with a market beta of 0.75. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Xianheng International Science&Technology a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Xianheng International Science&Technology (605056) the key facts are: market cap ¥5.2B, P/E 18.8x, revenue ¥4.5B, 52-week range 12.25-30.65. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Xianheng International Science&Technology's full fundamentals live
Get Xianheng International Science&Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.